Dose individualization of Beta-lactam and Ciprofloxacin in ICU patients: To TDM or not to TDM
- Universiteit Erasmus Medisch Centrum Rotterdam
- Promovendus Alan Abdulla
- Promoters Birgit Koch
- Co-Promoters Rik Endeman Anouk Muller
- Jaar 2018 - 2022
- A prospective observational PK/PD to study the target attainment for β-lactam antibiotics in critical ill patients and its associated risk factors.
- A multi-centre, randomised controlled trial to assess the efficacy and cost-effectiveness of model-based TDM of beta-lactam and fluoroquinolone antibiotics.